Community-Led Action Research in Oncology: Improving Symptom Management
| Status: | Completed |
|---|---|
| Conditions: | Anxiety, Anxiety, Cancer, Cancer, Depression, Other Indications, Hematology |
| Therapuetic Areas: | Hematology, Oncology, Psychiatry / Psychology, Other |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/17/2018 |
| Start Date: | July 24, 2017 |
| End Date: | December 31, 2017 |
This study will be conducted at La Liga Contra el Cancer in San Pedro Sula, Honduras. The
overall objective of this project is to improve symptom management for patients undergoing
chemotherapy in Honduras. The first step in this line of research is a "proof of concept"
feasibility study in which the investigators will demonstrate their ability to train nurses
to administer a non-pharmacological, telephone-delivered, symptom management program for
chemotherapy patients.
overall objective of this project is to improve symptom management for patients undergoing
chemotherapy in Honduras. The first step in this line of research is a "proof of concept"
feasibility study in which the investigators will demonstrate their ability to train nurses
to administer a non-pharmacological, telephone-delivered, symptom management program for
chemotherapy patients.
The investigators will use the team's previous experience delivering a standardized,
non-pharmacological palliative care intervention by telephone to inform a "proof of concept"
feasibility study in Honduras. They will train nurses at La Liga Contra el Cancer in San
Pedro Sula to conduct the telephone sessions and monitor their fidelity to treatment as they
enroll a minimum They will then evaluate the feasibility, acceptability, and potential
effectiveness of the program.
non-pharmacological palliative care intervention by telephone to inform a "proof of concept"
feasibility study in Honduras. They will train nurses at La Liga Contra el Cancer in San
Pedro Sula to conduct the telephone sessions and monitor their fidelity to treatment as they
enroll a minimum They will then evaluate the feasibility, acceptability, and potential
effectiveness of the program.
Inclusion Criteria:
- Patients who are over the age of 18 and are beginning a chemotherapy regimen to treat
any solid or hematological cancer will be eligible for the study.
Exclusion Criteria:
- Patients who do not start planned chemotherapy.
We found this trial at
2
sites
Click here to add this to my saved trials
Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock is a national leader in patient-centered health care and building...
Click here to add this to my saved trials